Recorded Presentations from the NCCN 10th Annual Congress: Hematologic Malignancies™

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of new advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients.

Target Audience

These activities are designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.

Additional information
Supporters: 

These activities are supported by educational funding provided by Amgen.

These activities are supported by an independent educational grant from Incyte Corporation.

These activities are supported by educational grants from AbbVie Inc.; Actelion Pharmaceuticals US, Inc.; Astellas Scientific and Medical Affairs, Inc.; Bristol-Myers Squibb; Celgene Corporation; Genentech; Gilead Sciences, Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Pharmacyclics LLC, An AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Seattle Genetics; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Course summary
Course opens: 
12/01/2015
Course expires: 
12/01/2016
Cost:
$0.00

These activities are approved for AMA PRA Category 1 Credit(s)™ and are also certified for nurses and pharmacists. Complete accreditation details are provided at the beginning of the individual activities.

 
Status
Price
Title
Locked
$0.00Included
Recorded Presentations from the NCCN 10th Annual Congress: Hematologic Malignancies™
Please login or register to take this course.
Locked
$0.00Included
Patient Case Studies & Panel Discussion (Double-hit Lymphoma, T-cell Lymphoma, Mantle Cell Lymphoma)
Please login or register to take this course.
Locked
$0.00Included
Optimizing Small Molecular Inhibitor Therapy for Chronic Lymphocytic Leukemia
Please login or register to take this course.
Locked
$0.00Included
Evolving Therapies for Follicular Lymphoma
Please login or register to take this course.
Locked
$0.00Included
Management of HIV-associated Non-Hodgkin’s Lymphomas
Please login or register to take this course.
Locked
$0.00Included
Patient Case Studies & Panel Discussion (Myeloproliferative Disorders, Elderly Myelofibrosis, Hemophagocytic Syndromes)
Please login or register to take this course.
Locked
$0.00Included
Evolving Targeted Management of Acute Myeloid Leukemia
Please login or register to take this course.
Locked
$0.00Included
Management of Myelodysplastic Syndromes
Please login or register to take this course.
Locked
$0.00Included
Management of Acute Lymphoblastic Leukemia
Please login or register to take this course.
Locked
$0.00Included
Survivorship Issues: Late Effects of Curative Therapy in Lymphoma Survivors
Please login or register to take this course.
Locked
$0.00Included
Patient Case Studies & Panel Discussion (Amyloidosis, POEMS Syndrome, Plasmacytoma)
Please login or register to take this course.
Locked
$0.00Included
Advances in Waldenström’s Macroglobulinemia
Please login or register to take this course.
Locked
$0.00Included
Management of Multiple Myeloma
Please login or register to take this course.
Locked
$0.00Included
Bone Health in Patients with Multiple Myeloma
Please login or register to take this course.
Locked
$0.00Included
Diagnosis and Management of Castleman Disease
Please login or register to take this course.
Locked
$0.00Included
Targeted Therapies for Relapsed or Refractory Classical Hodgkin Lymphoma
Please login or register to take this course.
Locked
$0.00Included
PET-Guided Treatment Approach for Advanced Stage Classical Hodgkin Lymphoma
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.